Aduro BioTech CEO Eric Dobmeier receives $6.2M in 2020
Aduro BioTech reports 2020 executive compensation
By ExecPay News
Published: April 14, 2022
Aduro BioTech reported fiscal year 2020 executive compensation information on April 14, 2022.
In 2020, five executives at Aduro BioTech received on average a compensation package of $3.5M, a 47% increase compared to previous year.
Average pay of disclosed executives at Aduro BioTech
Eric Dobmeier, Chief Executive Officer, received $6.2M in total. 67% of Dobmeier's compensation, or $4.2M, was in option awards. Dobmeier also received $256K in non-equity incentive plan, $438K in salary, $1.4M in stock awards, as well as $2K in other compensation.
Stephen T. Isaacs, Chief Executive Officer, received a compensation package of $4.2M, which increased by 28% compared to previous year. 27% of the compensation package, or $1.1M, was in other compensation.
Tom Frohlich, Chief Business Officer, earned $2.6M in 2020.
Alan Glicklich, Chief Medical Officer, received $2.4M in 2020.
Andrew King, Chief Scientific Officer, earned $2M in 2020.
Related executives
You may also like
Source: SEC filing on April 14, 2022.